Navigation Links
Quest Diagnostics to Acquire Lab-Related Clinical Outreach Operations of Dignity Health in California and Nevada

MADISON, N.J. and SAN FRANCISCO, April 17, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has entered into a definitive agreement to acquire lab-related clinical outreach service operations of Dignity Health, a hospital system based in California.

Under the agreement, Quest Diagnostics will acquire operations through which Dignity Health currently provides outreach diagnostic information services to patients and physician offices in parts of California and Nevada. Outreach services are provided by hospitals to physicians and patients outside of a hospital setting. Dignity Health's hospital-based laboratories are not included in the sale. Quest Diagnostics will perform testing from the acquired operations through its clinical laboratories in West Hills and Sacramento, Calif., and Las Vegas, Nevada.

The transaction is expected to be completed in June 2013, assuming customary approvals. Additional terms were not disclosed.

"With this acquisition, patients, physicians and payers in California and Nevada will gain access to a wider range of high-quality, innovative diagnostic information services and patient service center options at lower cost," said Steve Rusckowski , president and chief executive officer, Quest Diagnostics. "In addition, this acquisition is consistent with our five-point strategy, which includes delivering disciplined capital deployment and driving one to two percent in growth per year through strategically aligned fold-in acquisitions."

Quest Diagnostics expects the transaction to be neutral to adjusted earnings in 2013 and modestly accretive to earnings per share in 2014. The company also expects it to contribute about half a percentage point to consolidated revenues annually. 

"This agreement will provide patients and physicians with continued access to high-quality, cost effective diagnostic information services through Quest Diagnostics," said Lloyd Dean , president/CEO of Dignity Health. "Quest's specialization in diagnostic information services will enable this important service line to remain competitive while also allowing Dignity Health to invest more strategically in acute and ambulatory clinical care."

Assuming its completion, the transaction will be the second acquisition by Quest Diagnostics of an outreach business in 2013. In January 2013, Quest Diagnostics acquired the clinical and anatomic-pathology outreach laboratory businesses of Massachusetts-based UMass Memorial Medical Center, a member of UMass Memorial Health Care.

"Our agreement with Dignity Health underscores the attractiveness of Quest Diagnostics as a provider of low-cost, high-quality diagnostic information services to hospital systems which, in light of health care reform and growing reimbursement pressures, are considering strategic alternatives for their lab outreach businesses," said Rusckowski.

About Dignity Health

Headquartered in San Francisco, Dignity Health is dedicated to providing compassionate, high-quality and affordable patient-centered care with special attention to the poor and underserved.  In 2011, Dignity Health provided $1.6 billion in charitable care and services.  For more information, please visit the Dignity Health website at You can also follow Dignity Health on Twitter and Facebook.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic information services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at Follow us at and

Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.  

Quest Diagnostics Contacts:

Dan Haemmerle (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800

SOURCE Quest Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment
2. Questcor to Report First Quarter Results on April 30, 2013
3. Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
4. Recreational Marijuana Users More Likely To Misuse Prescription Drugs, According to National Study by Quest Diagnostics
5. Quest Diagnostics To Release First Quarter 2013 Financial Results On April 17
6. Prescription Drug Misuse Remains at Alarming Levels, According to National Study by Quest Diagnostics
7. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
8. Phonak Expands Its Quest Platform with New Product Lines
9. Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs
10. Disinfectant Qualification Questions are Answered for Sterile Drug Manufacturers in New White Paper
11. Quest Diagnostics Launches Dementia Diagnostic Panel, First in Industry for Treatable Forms of Cognitive Impairment Based on Medical Guidelines
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... , ... Khanna Vision Institute based in Los Angeles, announced that Dr. Khanna ... Peer Certification by the Board is done so the public knows that the Doctor ... after the completion of three years of training or Residency in Ophthalmology. This is ...
(Date:11/29/2015)... ... , ... Key Housing, a top-rated corporate housing service for the San Jose ... Epic. In showcasing this featured apartment community in San Jose, Key Housing is helping ... efficiently find housing suitable to their needs by showcasing quality housing. , “San Jose ...
(Date:11/28/2015)... ... 2015 , ... Pixel Film Studios is back again with ProPanel: Pulse ... are endless. Users have full control over angle of view, speed method, start point, ... sure to get heads to turn. , ProPanel: Pulse offers fully customizable pulsating shape ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... affecting the health care in America. As people age, more care is needed, ... costs are rising, and medical professionals are being overworked. The forgotten part of ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
Breaking Medicine News(10 mins):